PF-1805

N/A

Report date: 2024/09/02 16:28:06
NME

Base Information

Drug NamePF-1805
Drug Alias NamePF-1805PF1805
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAtrial natriuretic peptide receptor type B modulators
TargetsAtrial natriuretic peptide receptor type B
Therapy Area/IndicationsAchondroplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmunoForge Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesImmunoForge Co Ltd
Inactive CompaniesN/A
Active IndicationsAchondroplasia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A